Published on: Dec 01, 2016 at Bioscience Technology

Halozyme and Genentech to Collaborate on Clinical Cancer Trials

By : Bioscience Technology

Halozyme Therapeutics Inc. (tag) has partnered with Genentech (tag) to conduct clinical studies to evaluate Halozyme’s investigational drug PEGPH20 in six tumor types, starting with gastric cancer patients. 

Read More
SHARE